Company Research
Below is a complete list of all the research that we have produced, in chronological order.
IMAX Corporation: The Plot Thickens Ahead of 2/23 Earnings Report
02/21/12 -
IMAX Corporation (IMAX, $25.31) -- The Plot Thickens Ahead of 2/23 Earnings Report
- Box office revenues continue to improve after a lackluster 2011
- Long-term story gets stronger with new US-China film industry agreement last week.
We highlighted IMAX as a “Stock of Interest” in our 12/19/2011 report. We were compelled by a very strong long-term story as the company is on a trajectory to triple its commercial theater network over this decade with predominantly international theaters. Making the story even more bullish is that international theaters are nearly doubling the gross box office of the domestic theaters. We also thought that IMAX was a timely idea, with the stock overly punished for a very poor showing from the Hollywood studios in 2011 that was set to improve. Since our initial report we have seen continued improvement from the box office and a very strong enhancement to the company’s second most important market, China.
read more...